Prognostic classification of breast ductal carcinoma-in-situ
- 1 May 1995
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 345 (8958), 1154-1157
- https://doi.org/10.1016/s0140-6736(95)90982-6
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Loss of heterozygosity in ductal carcinoma in situ of the breastThe Journal of Pathology, 1995
- Consistency of histopathological reporting of breast lesions detected by screening: Findings of the U.K. National External Quality Assessment (EQA) schemeEuropean Journal Of Cancer, 1994
- Lumpectomy Compared with Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast CancerNew England Journal of Medicine, 1993
- Ductal Carcinoma In Situ of the Female BreastThe American Journal of Surgical Pathology, 1992
- Estrogen receptor immunohistoohemistry in carcinoma in situ of the breastCancer, 1992
- Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinomain situBreast Cancer Research and Treatment, 1991
- Borderline Epithelial Lesions of the BreastThe American Journal of Surgical Pathology, 1991
- Duct Carcinoma in Situ: Pathology and TreatmentSurgical Clinics of North America, 1990
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Neu-Protein Overexpression in Breast CancerNew England Journal of Medicine, 1988